● 315 employees nationwide
● 2 RD laboratories (Pingshan, Nanshan)
● 3 manufacturing facilities
● APIs, Nanjing Lishui, JiangSu, 4 production lines in compliance with FDA
● APIs, Xian’ning, HuBei, 16 production lines in compliance with FDA(under construction)
● Finished products, 2 dosage lines in Shenzhen Pingshan, GuangDong
● 7 products submitted ANDA to CFDA, 5 products under filing
● 1 product submitted IND to CFDA
● 1 product submitted VMF (US-FDA) and obtained CEP certificate
-4 peptide production lines, passed USFDA and EDQM inspection with NAI
-4 production lines in compliance with GMP guidelines
- 16 production lines in compliance with cGMP standards